Barclays’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,900
Closed -$1.03M 5564
2026
Q1
$1.03M Sell
4,900
-4,800
-49% -$1.21M ﹤0.01% 2744
2025
Q4
$2.76M Hold
9,700
﹤0.01% 2697
2025
Q3
$2.99M Buy
9,700
+8,800
+978% +$2.76M ﹤0.01% 2570
2025
Q2
$283K Buy
+900
New +$260K ﹤0.01% 4078
2024
Q4
Sell
-2,100
Closed -$489K 5433
2024
Q3
$489K Buy
+2,100
New +$431K ﹤0.01% 3787
2024
Q2
Sell
-2,300
Closed -$394K 5205
2024
Q1
$394K Sell
2,300
-2,300
-50% -$429K ﹤0.01% 3734
2023
Q4
$998K Buy
+4,600
New +$789K ﹤0.01% 3435

Other funds holding PODD

Barclays's PODD Position: Q2 2026 in Review

Barclays reduced its Insulet (PODD) stake by 12% in Q2 2026, selling an estimated $2.51M and leaving 113,472 shares worth $17.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1212.

Barclays first reported a position in PODD in Q2 2013 and has held it in 53 quarters since. The position peaked at $73.1M in Q1 2024. 726 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Barclays held 113,472 shares of Insulet worth $17.3M as of Q2 2026.
  • Barclays sold 15,040 Insulet shares in Q2 2026, an estimated $2.51M.
  • Insulet made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1212 holding.
  • Barclays first reported a position in Insulet in Q2 2013 and has held it in 53 quarters since.
  • Barclays's Insulet position peaked at $73.1M in Q1 2024.
  • 726 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.